Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trials on Detection of Hepatocellular Carcinoma With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC and T Cells

NCT03483922 is registered in ClinicalTrials.gov with HKGepitherapeutics as lead sponsor.

NCT NCT03483922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03483922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trials on Detection of Hepatocellular Carcinoma With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC and T Cells
Lead sponsor
HKGepitherapeutics
Phase
Observational
Overall status
Completed
Start date
August 20, 2018
Completion date
November 1, 2020
Enrollment
403 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma